RNS Number : 0529K Rosebank Industries PLC 29 June 2026  

29 June 2026

Rosebank Industries plc

("Rosebank" or the "Company")

Director/PDMR Share Dealing

Rosebank announces that it has been informed that Simon Peckham, Chief Executive, purchased 109,737 Ordinary Shares of no par value in the Company ("Ordinary Shares") at a price of £3.1892 pence per Ordinary Share on 26 June 2026. In total, Simon Peckham holds 2,775,585 Ordinary Shares in the Company.

Further details relating to the PDMR transaction are set out in the table below.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Simon Peckham

2

Reason for the notification

a)

Position/status

Chief Executive / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rosebank Industries plc

b)

LEI

2138005KFPHBAEW69F51

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of no par value

JE00BSBJ5M88

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£3.1892

109,737

d)

Aggregated information

-      Volume

-      Price

-      Total

N/A

e)

Date of the transaction

26 June 2026

f)

Place of the transaction

London Stock Exchange

Enquiries

Rosebank

Simon Peckham, Chief Executive

Liam Butterworth, Chief Operating Officer

Matthew Richards, Group Finance Director

Via Montfort Communications

www.rosebankindustries.com

Montfort Communications

Nick Miles

Charlotte McMullen

+44 7739 701 634

+44 7921 881 800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  DSHFDLFLQQLBBBE